Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (14380)	2/6/1998 6:06:00 PM
From: medsunman	Read Replies (1) \| Respond to of 32384

A great day for LGND. Happy for everyone on the thread - even FUGAZI, because I can't believe he really shorted LGND - not with those stellar Phase III Panretin results, an NDA in the offing, and projections of profit in '99. If we see some efficacy in any of the Phase II trials, anything which would hint at a bigger market for Panretin or Targretin, then this thing will really take off. I predict that it will be Andy buying the wine next time.